OGT Licenses Tridend Tech to UK Biotech MassTag | GenomeWeb
NEW YORK (GenomeWeb News) — Oxford Gene Technology today said it has granted UK biotech MassTag Technologies licensing rights to its Tridend technology.
 
The company said the option on the license will become exclusive when MassTag completes a fund-raising campaign. Also through the agreement, OGT will become a minority shareholder in MassTag.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.